NOVEL THERAPIES FOR DOXORUBICIN CARDIOTOXICITY

$85,015R41FY2008HLNIH

Nova-Ther Technologies, Westerville OH

Investigators

John Anthony Bauercontact

View original record on NIH RePORTER →

NOVEL THERAPIES FOR DOXORUBICIN CARDIOTOXICITY · GrantIndex